Patents by Inventor Marianne Lohr

Marianne Lohr has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • VEGF peptides and their use for inhibiting angiogenesis
    Patent number: 7223835
    Abstract: A peptide having part or all of the amino acid sequence QKRKRKKSRYKSWSVP (which is part of VEGF) has the ability to inhibit angiogenesis.
    Type: Grant
    Filed: October 25, 2001
    Date of Patent: May 29, 2007
    Assignee: Ark Therapeutics Ltd.
    Inventors: David Selwood, Ian Zachary, Haiyan Jia, Marianne Lohr, Dana Davis
  • Vegf peptides and their use for inhibiting angiogenesis
    Publication number: 20040054143
    Abstract: A peptide having part or all of the amino acid sequence QKRKRKKSRYKSWSVP (which is part of VEGF) has the ability to inhibit angiogenesis.
    Type: Application
    Filed: August 6, 2003
    Publication date: March 18, 2004
    Inventors: David Selwood, Ian Zachary, Haiyan Jia, Marianne Lohr, Dana Davis
  • Process for the preparation of aromatic fluorinated compounds and novel diamides
    Patent number: 5672765
    Abstract: Aromatic, ring-fluorinated compounds are prepared by reaction of corresponding chlorine compounds or bromine compounds with alkali metal fluorides using a diamide as solvent. Most of the diamides which can be used are novel compounds.
    Type: Grant
    Filed: July 14, 1995
    Date of Patent: September 30, 1997
    Assignee: Bayer Aktiengesellschaft
    Inventors: Albrecht Marhold, Marianne Lohr, Heinrich Wamhoff